GLIOSARCOMA
Clinical trials for GLIOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new GLIOSARCOMA trials appear
Sign up with your email to follow new studies for GLIOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test new pill to fight deadly brain tumors
Disease control TerminatedThis early-stage study tested a new oral drug called navtemadlin (AMG 232) for glioblastoma, a fast-growing brain cancer. The trial had two parts: first, to see if the drug could reach brain tumor tissue in patients whose cancer had returned; second, to find a safe dose to combin…
Matched conditions: GLIOSARCOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for fighting back against aggressive brain tumors
Disease control TerminatedThis study tested if adding an experimental drug called Zotiraciclib to a standard chemotherapy (temozolomide) could better control aggressive brain tumors that have returned after initial treatment. The trial had two parts: first to find a safe dose, then to compare how long the…
Matched conditions: GLIOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 04, 2026 15:29 UTC